Astria Therapeutics Inc (ATXS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2015 | 06-2015 | 03-2015 | 12-2014 | 09-2014 | |
| Operating Expenses | 8,201 | 7,764 | 6,360 | 0 | 5,970 |
| Operating Income | -8,201 | -7,764 | -6,360 | N/A | -5,970 |
| Interest Expense | 282 | 279 | 149 | 0 | 57 |
| Other Income | -2 | 4 | 9 | 0 | 2 |
| Pre-tax Income | -8,485 | -8,039 | -6,500 | 0 | -6,025 |
| Net Income Continuous | -8,485 | -8,039 | -6,500 | N/A | -6,025 |
| Net Income | $-8,485 | $-8,039 | $-6,500 | $N/A | $-6,025 |
| EPS Basic Total Ops | -32.99 | -484.10 | -788.24 | N/A | -812.84 |
| EPS Basic Continuous Ops | -33.27 | -483.89 | -788.37 | N/A | -812.59 |
| EPS Diluted Total Ops | -32.99 | -484.10 | -788.24 | N/A | -812.84 |
| EPS Diluted Continuous Ops | -33.27 | -483.89 | -788.37 | N/A | -812.59 |
| EBITDA(a) | $-8,164 | $-7,723 | $-6,308 | $N/A | $-5,910 |